Abstract
This month’s CJASN Controversies section presents two discussions of interactions between industry and the KDOQI patient care guidelines for the treatment of anemia in chronic kidney disease and ESRD. In subsequent issues we will present invited commentaries from other authorities in this area and invite our general readership to express their opinions.
- Copyright © 2007 by the American Society of Nephrology